199 related articles for article (PubMed ID: 8575586)
1. Blood cell redistribution in the lung after administration of recombinant human granulocyte-macrophage colony-stimulating factor.
Gatti E; Scagliotti GV; Ferrari G; Mutti L; Pozzi E; Stacchini A; Fubini L; Aglietta M
Eur Respir J; 1995 Sep; 8(9):1566-71. PubMed ID: 8575586
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.
Wislez M; Fleury-Feith J; Rabbe N; Moreau J; Cesari D; Milleron B; Mayaud C; Antoine M; Soler P; Cadranel J
Am J Pathol; 2001 Oct; 159(4):1423-33. PubMed ID: 11583970
[TBL] [Abstract][Full Text] [Related]
3. Selective enhancement of GM-CSF, TNF-alpha, IL-1 beta and IL-8 production by monocytes and macrophages of asthmatic subjects.
Hallsworth MP; Soh CP; Lane SJ; Arm JP; Lee TH
Eur Respir J; 1994 Jun; 7(6):1096-102. PubMed ID: 7925879
[TBL] [Abstract][Full Text] [Related]
4. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha.
Aloisi F; Carè A; Borsellino G; Gallo P; Rosa S; Bassani A; Cabibbo A; Testa U; Levi G; Peschle C
J Immunol; 1992 Oct; 149(7):2358-66. PubMed ID: 1382099
[TBL] [Abstract][Full Text] [Related]
5. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
6. Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapy.
Thomassen MJ; Ahmad M; Barna BP; Antal J; Wiedemann HP; Meeker DP; Klein J; Bauer L; Gibson V; Andresen S
Cancer Res; 1991 Feb; 51(3):857-62. PubMed ID: 1988125
[TBL] [Abstract][Full Text] [Related]
7. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
Baiocchi G; Scambia G; Benedetti P; Menichella G; Testa U; Pierelli L; Martucci R; Foddai ML; Bizzi B; Mancuso S
Cancer Res; 1993 Mar; 53(6):1297-303. PubMed ID: 7680283
[TBL] [Abstract][Full Text] [Related]
8. Regulation of granulocyte macrophage colony stimulating factor production by human articular chondrocytes. Induction by both tumor necrosis factor-alpha and interleukin 1, downregulation by transforming growth factor beta and upregulation by fibroblast growth factor.
Alsalameh S; Firestein GS; Oez S; Kurrle R; Kalden JR; Burmester GR
J Rheumatol; 1994 Jun; 21(6):993-1002. PubMed ID: 7932447
[TBL] [Abstract][Full Text] [Related]
9. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha.
Cromwell O; Hamid Q; Corrigan CJ; Barkans J; Meng Q; Collins PD; Kay AB
Immunology; 1992 Nov; 77(3):330-7. PubMed ID: 1478679
[TBL] [Abstract][Full Text] [Related]
10. CD1a+ and CD1a- accessory cells from human bronchoalveolar lavage differ in allostimulatory potential and cytokine production.
van Haarst JM; Verhoeven GT; de Wit HJ; Hoogsteden HC; Debets R; Drexhage HA
Am J Respir Cell Mol Biol; 1996 Dec; 15(6):752-9. PubMed ID: 8969270
[TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
12. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
13. Carryover of cigarette smoke effects on hematopoietic cytokines to F1 mouse litters.
Shukla M; Kumar P; Mishra V; Chaudhari BP; Munjal AK; Tripathi SS; Raisuddin S; Paul BN
Mol Immunol; 2011 Sep; 48(15-16):1809-17. PubMed ID: 21636132
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis.
Ishioka S; Saito T; Hiyama K; Haruta Y; Maeda A; Hozawa S; Inamizu T; Yamakido M
Sarcoidosis Vasc Diffuse Lung Dis; 1996 Sep; 13(2):139-45. PubMed ID: 8893383
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH
Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia.
Cannistra SA; DiCarlo J; Groshek P; Kanakura Y; Berg D; Mayer RJ; Griffin JD
Leukemia; 1991 Mar; 5(3):230-8. PubMed ID: 1826536
[TBL] [Abstract][Full Text] [Related]
18. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
Neta R; Oppenheim JJ; Douches SD
J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
[TBL] [Abstract][Full Text] [Related]
19. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
[TBL] [Abstract][Full Text] [Related]
20. Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation.
Agostini C; Trentin L; Zambello R; Bulian P; Caenazzo C; Cipriani A; Cadrobbi P; Garbisa S; Semenzato G
J Immunol; 1992 Nov; 149(10):3379-85. PubMed ID: 1431112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
